Cabotamig

• UNSPSC Description:

  Cabotamig is an anti-CD3E/CDH17 monoclonal antibody[1].

• Target Antigen:

  Others

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/cabotamig.html

• References & Citations:

  [1]Cabotamig

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 1